Your browser doesn't support javascript.
loading
Influenza vaccination and single cell multiomics reveal sex dimorphic immune imprints of prior mild COVID-19.
Sparks, Rachel; Lau, William W; Liu, Can; Han, Kyu Lee; Vrindten, Kiera L; Sun, Guangping; Cox, Milann; Andrews, Sarah F; Bansal, Neha; Failla, Laura E; Manischewitz, Jody; Grubbs, Gabrielle; King, Lisa R; Koroleva, Galina; Leimenstoll, Stephanie; Snow, LaQuita; Chen, Jinguo; Tang, Juanjie; Mukherjee, Amrita; Sellers, Brian A; Apps, Richard; McDermott, Adrian B; Martins, Andrew J; Bloch, Evan M; Golding, Hana; Khurana, Surender; Tsang, John S.
Afiliação
  • Sparks R; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Lau WW; These authors contributed equally.
  • Liu C; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Han KL; These authors contributed equally.
  • Vrindten KL; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Sun G; Graduate Program in Biological Sciences, University of Maryland, College Park, MD, USA.
  • Cox M; These authors contributed equally.
  • Andrews SF; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Bansal N; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Failla LE; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Manischewitz J; Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA.
  • Grubbs G; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • King LR; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
  • Koroleva G; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Leimenstoll S; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Snow L; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.
  • Chen J; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.
  • Tang J; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Mukherjee A; Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, USA.
  • Sellers BA; Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, USA.
  • McDermott AB; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Martins AJ; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.
  • Bloch EM; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Golding H; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Khurana S; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Tsang JS; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
medRxiv ; 2022 Sep 01.
Article em En | MEDLINE | ID: mdl-35233581
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article